Advertisement

Ad promo image large
  • Published Date

    October 11, 2019
    This ad was originally published on this date and may contain an offer that is no longer valid. To learn more about this business and its most recent offers, click here.

Ad Text

Idiopathic Pulmonary Fibrosis (IPF), a Disease of the Lungs Join us for a FREE educational event sponsored by Genentech. Discover more about IPF, a condition affecting up to 40,000 new Americans every year Hear from a speaker who has IPF and a doctor who specializes in the disease Meet other people living with IPF Educate yourself on tips and information about proactively managing your IPF DATE: PRESENTERS: Scott Beegle, M.D. Pulmonologist and expert in IPF Saturday, October 26, 2019 Doors open at: 9:30 AM Program starts at: 10:00 AM Jim R. Living with IPF LOCATION: Clarion Inn Seekonk-Providence 940 Fall River Avenue Seekonk, MA 02771 Complimentary refreshments and parking will be provided. Wheelchair accessible. CALL TO RSVP TODAY: 1-800-234-0494 TAKE AN ACTIVE ROLE AGAINST YOUR IPF TODAY 2019 Genentech USA, Inc. All rights reserved. Genentech ESB/080515/0385(1) a(3) 01/19 A Member of the Roche Group Idiopathic Pulmonary Fibrosis (IPF), a Disease of the Lungs Join us for a FREE educational event sponsored by Genentech. Discover more about IPF, a condition affecting up to 40,000 new Americans every year Hear from a speaker who has IPF and a doctor who specializes in the disease Meet other people living with IPF Educate yourself on tips and information about proactively managing your IPF DATE: PRESENTERS: Scott Beegle, M.D. Pulmonologist and expert in IPF Saturday, October 26, 2019 Doors open at: 9:30 AM Program starts at: 10:00 AM Jim R. Living with IPF LOCATION: Clarion Inn Seekonk-Providence 940 Fall River Avenue Seekonk, MA 02771 Complimentary refreshments and parking will be provided. Wheelchair accessible. CALL TO RSVP TODAY: 1-800-234-0494 TAKE AN ACTIVE ROLE AGAINST YOUR IPF TODAY 2019 Genentech USA, Inc. All rights reserved. Genentech ESB/080515/0385(1) a(3) 01/19 A Member of the Roche Group